A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke - Concepedia

Concepedia

Publication | Closed Access

A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke

115

Citations

19

References

1992

Year

Alexander G.G. Turpie, Michael Gent, Mark Levine, Jeffrey S. Ginsberg, Peter Powers, Jacques Leclerc, William Geerts, Richard M. Jay, Jean Neemeh, Marian Klimek,

Annals of Internal Medicine

Abstract

Low-molecular-weight heparinoid, given in a fixed dose of 750 anti-factor Xa units subcutaneously twice daily, is more effective than subcutaneous low-dose heparin for the prevention of deep vein thrombosis in patients with acute ischemic stroke.

References

	Year	Citations

Page 1